Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2004 Jul;89(7):620–624. doi: 10.1136/adc.2003.030411

Sublingual immunotherapy in asthma and rhinoconjunctivitis; systematic review of paediatric literature

S Miceli 1, M Macchiaiolo 1, G Zorzi 1, S Tripodi 1
PMCID: PMC1719990  PMID: 15210490

Abstract

Aims: To evaluate the clinical efficacy of sublingual immunotherapy (SLIT) in respiratory allergy in children.

Methods: A systematic literature review was conducted. The search was focused on all the double blind (and double dummy if necessary) studies. Search strategy: Medline, Embase, Cochrane Controlled Trial Register, Abstract of Cochrane Airways Group, hand search, and archives of some SLIT producers. All the selected studies were assessed and evaluated for quality in a standardised independent way.

Results: Eight randomised, double blind, placebo controlled studies on SLIT were selected. Five studies were run with house dust mite (HDM), one with olive pollen, one with wall pellitory (Parietaria) pollen, and one with grass pollen. A quantitative evaluation of the studies was not possible because the outcomes and the results of single studies were presented according to different criteria. Therefore only qualitative analysis was performed. No clinically relevant results were shown, independently from statistical significance, in the use of SLIT for respiratory allergies due to seasonal allergens (olive, wall pellitory, and grass pollens) and, on the whole, for rhinoconjunctivitis due to HDM in children. For mild to moderate persistent asthma due to HDM, statistically significant and low to moderate relevant clinical effects were observed.

Conclusions: SLIT can be currently considered to have low to moderate clinical efficacy in children of at least 4 years of age, monosensitised to HDM, and suffering from mild to moderate persistent asthma. This benefit seems to be adjunctive with respect to the environmental preventive measures against HDM.

Full Text

The Full Text of this article is available as a PDF (76.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. André C., Vatrinet C., Galvain S., Carat F., Sicard H. Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol. 2000 Mar;121(3):229–234. doi: 10.1159/000024322. [DOI] [PubMed] [Google Scholar]
  2. Bahçeciler N. N., Işik U., Barlan I. B., Başaran M. M. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study. Pediatr Pulmonol. 2001 Jul;32(1):49–55. doi: 10.1002/ppul.1088. [DOI] [PubMed] [Google Scholar]
  3. Bousquet J., Van Cauwenberge P., Khaltaev N., Aria Workshop Group. World Health Organization Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001 Nov;108(5 Suppl):S147–S334. doi: 10.1067/mai.2001.118891. [DOI] [PubMed] [Google Scholar]
  4. Caffarelli C., Sensi L. G., Marcucci F., Cavagni G. Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial. Allergy. 2000 Dec;55(12):1142–1147. doi: 10.1034/j.1398-9995.2000.00655.x. [DOI] [PubMed] [Google Scholar]
  5. Clavel R., Bousquet J., André C. Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis. Allergy. 1998 May;53(5):493–498. doi: 10.1111/j.1398-9995.1998.tb04086.x. [DOI] [PubMed] [Google Scholar]
  6. Creticos P. S., Adkinson N. F., Jr, Kagey-Sobotka A., Proud D., Meier H. L., Naclerio R. M., Lichtenstein L. M., Norman P. S. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. J Clin Invest. 1985 Dec;76(6):2247–2253. doi: 10.1172/JCI112233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Di Rienzo V., Pagani A., Parmiani S., Passalacqua G., Canonica G. W. Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients. Allergy. 1999 Oct;54(10):1110–1113. doi: 10.1034/j.1398-9995.1999.00267.x. [DOI] [PubMed] [Google Scholar]
  8. Douglass J., O'Hehir R. Specific allergen immunotherapy: time for alternatives? Clin Exp Allergy. 2002 Jan;32(1):1–3. doi: 10.1046/j.0022-0477.2001.01278.x. [DOI] [PubMed] [Google Scholar]
  9. Fanta C., Bohle B., Hirt W., Siemann U., Horak F., Kraft D., Ebner H., Ebner C. Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy. Int Arch Allergy Immunol. 1999 Nov;120(3):218–224. doi: 10.1159/000024270. [DOI] [PubMed] [Google Scholar]
  10. Frew A. J., Smith H. E. Sublingual immunotherapy. J Allergy Clin Immunol. 2001 Mar;107(3):441–444. doi: 10.1067/mai.2001.113525. [DOI] [PubMed] [Google Scholar]
  11. Hirsch T., Sähn M., Leupold W. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children. Pediatr Allergy Immunol. 1997 Feb;8(1):21–27. doi: 10.1111/j.1399-3038.1997.tb00138.x. [DOI] [PubMed] [Google Scholar]
  12. Ippoliti Flora, De Santis Wladimiro, Volterrani Anna, Lenti Luisa, Canitano Nicoletta, Lucarelli Sandra, Frediani Tullio. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol. 2003 Jun;14(3):216–221. doi: 10.1034/j.1399-3038.2003.00025.x. [DOI] [PubMed] [Google Scholar]
  13. Kägi M. K., Wüthrich B. Different methods of local allergen-specific immunotherapy. Allergy. 2002 May;57(5):379–388. doi: 10.1034/j.1398-9995.2002.01153.x. [DOI] [PubMed] [Google Scholar]
  14. La Rosa M., Ranno C., André C., Carat F., Tosca M. A., Canonica G. W. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol. 1999 Aug;104(2 Pt 1):425–432. doi: 10.1016/s0091-6749(99)70388-x. [DOI] [PubMed] [Google Scholar]
  15. Lichtenstein L. M., Ishizaka K., Norman P. S., Sobotka A. K., Hill B. M. IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy. J Clin Invest. 1973 Feb;52(2):472–482. doi: 10.1172/JCI107204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Moshkevich V. S., Esenzhanova G. M. Mestnoe spetsificheskoe lechenie pylevoi bronkhial'noi astmy. Ter Arkh. 1982;54(4):72–76. [PubMed] [Google Scholar]
  17. Pajno G. B., Morabito L., Barberio G., Parmiani S. Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study. Allergy. 2000 Sep;55(9):842–849. doi: 10.1034/j.1398-9995.2000.00495.x. [DOI] [PubMed] [Google Scholar]
  18. Passalacqua G., Albano M., Fregonese L., Riccio A., Pronzato C., Mela G. S., Canonica G. W. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet. 1998 Feb 28;351(9103):629–632. doi: 10.1016/S0140-6736(97)07055-4. [DOI] [PubMed] [Google Scholar]
  19. Passalacqua G., Albano M., Riccio A., Fregonese L., Puccinelli P., Parmiani S., Canonica G. W. Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial. J Allergy Clin Immunol. 1999 Nov;104(5):964–968. doi: 10.1016/s0091-6749(99)70076-x. [DOI] [PubMed] [Google Scholar]
  20. Passalacqua G., Canonica G. W. Allergen-specific sublingual immunotherapy for respiratory allergy. BioDrugs. 2001;15(8):509–519. doi: 10.2165/00063030-200115080-00003. [DOI] [PubMed] [Google Scholar]
  21. Sabbah A., Hassoun S., Le Sellin J., André C., Sicard H. A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy. 1994 May;49(5):309–313. doi: 10.1111/j.1398-9995.1994.tb02273.x. [DOI] [PubMed] [Google Scholar]
  22. Secrist H., DeKruyff R. H., Umetsu D. T. Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J Exp Med. 1995 Mar 1;181(3):1081–1089. doi: 10.1084/jem.181.3.1081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Silvestri Michela, Spallarossa Daniela, Battistini Elena, Sabatini Federica, Pecora Silvia, Parmiani Silvano, Rossi Giovanni A. Changes in inflammatory and clinical parameters and in bronchial hyperreactivity asthmatic children sensitized to house dust mites following sublingual immunotherapy. J Investig Allergol Clin Immunol. 2002;12(1):52–59. [PubMed] [Google Scholar]
  24. Tari M. G., Mancino M., Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Allergol Immunopathol (Madr) 1990 Sep-Oct;18(5):277–284. [PubMed] [Google Scholar]
  25. Varney V. A., Hamid Q. A., Gaga M., Ying S., Jacobson M., Frew A. J., Kay A. B., Durham S. R. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest. 1993 Aug;92(2):644–651. doi: 10.1172/JCI116633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Vourdas D., Syrigou E., Potamianou P., Carat F., Batard T., André C., Papageorgiou P. S. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. Allergy. 1998 Jul;53(7):662–672. doi: 10.1111/j.1398-9995.1998.tb03952.x. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES